Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. II. Influence of phenobarbital comedication
- 30 June 1993
- journal article
- Published by Elsevier in Epilepsy Research
- Vol. 15 (2) , 113-131
- https://doi.org/10.1016/0920-1211(93)90092-l
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Single-dose tolerance and pharmacokinetics of 2-n-propyl-2(E)-pentenoate (Δ2(E)-valproate) in healthy male volunteersInternational Journal of Clinical Pharmacy, 1992
- Metabolism of valproate to hepatotoxic intermediatesInternational Journal of Clinical Pharmacy, 1992
- Quantitative determination of valproic acid and 14 metabolities in serum and urine by gas chromatography/mass spectrometryBiomedical Chromatography, 1992
- Valproate Metabolites in Serum and Urine During Antiepileptic Therapy in Children with Infantile Spasms: Abnormal Metabolite Pattern Associated with Reversible HepatotoxicityEpilepsia, 1992
- Valproate Metabolism During Hepatotoxicity Associated with the DrugQJM: An International Journal of Medicine, 1990
- The High Incidence of Valproate Hepatotoxicity in Infants May Relate to Familial Metabolic DefectsCanadian Journal of Neurological Sciences, 1990
- Metabolic activation of valproic acid and drug-mediated hepatotoxicity. Role of the terminal olefin, 2-n-propyl-4-pentenoic acidChemical Research in Toxicology, 1988
- Valproic acid hepatic fatalitiesNeurology, 1987
- Inhibition of medium-chain fatty acid β-oxidationinvitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acidBiochemical and Biophysical Research Communications, 1985
- Decreased serum carnitine in valproate induced Reye syndromeEuropean Journal of Pediatrics, 1982